Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study

BACKGROUND: The CC-chemokine receptor 4 (CCR4) is thought potentially to play a critical role in asthma pathogenesis due to its ability to recruit type 2 T-helper lymphocytes to the inflamed airways. Therefore, CCR4 provides an excellent target for anti-inflammatory therapy. METHODS: The safety, tol...

Descripción completa

Detalles Bibliográficos
Autores principales: Cahn, Anthony, Hodgson, Simon, Wilson, Robert, Robertson, Jonathan, Watson, Joanna, Beerahee, Misba, Hughes, Steve C, Young, Graeme, Graves, Rebecca, Hall, David, van Marle, Sjoerd, Solari, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599276/
https://www.ncbi.nlm.nih.gov/pubmed/23448278
http://dx.doi.org/10.1186/2050-6511-14-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599276/
https://www.ncbi.nlm.nih.gov/pubmed/23448278
http://dx.doi.org/10.1186/2050-6511-14-14

Ejemplares similares